Unique Gonadotropin Pen Introduced to SDFC Patients
Last month, the Food and Drug Administration (FDA) has approved a new device developed for the delivery of follicle stimulating hormone (FSH) Gonadotropin, which is used during infertility treatment. Drs. Hummel and Kettel have found that the device, which is called Gonal-f® RFF Pen, make injections for patients much more tolerable. The pen is pre-filled and ready to use. The flexible multi-dose FSH is designed for infertility patients, who simply select their dosage on the pen’s dial before injection.
“Our patients have been waiting for the FDA approval since they heard about it during the research studies”, comments Dr. Kettel, who conducted one of the studies for Serono, “It is a relief for every patient, who is afraid of needles”. Gonal-f RFF Pen is available in three sizes with single-dose and multi-dose vials of 300 IU, 450 IU or 900 IU.